HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads
about
The role of NK cells in HIV-1 protection: autologous, allogeneic or both?The Significance of a Common Idiotype (1F7) on Antibodies against Human Immune Deficiency Virus Type 1 and Hepatitis C VirusMother-infant HIV transmission: do maternal HIV-specific antibodies protect the infant?Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cellsADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challengeStructural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 InfectionDiverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 bindingElastomeric negative acoustic contrast particles for affinity capture assays.Lessons learned from human HIV vaccine trials.Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan Women.HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype.Epitope target structures of Fc-mediated effector function during HIV-1 acquisition.Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesCooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host-microbial mutualismRationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individualsSlaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cellsThe role of cell-associated virus in mother-to-child HIV transmission.Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African womenNatural killer cell and T-cell subset distributions and activation influence susceptibility to perinatal HIV-1 infection.Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality.Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults.Antibodies for prevention of mother-to-child transmission of HIV-1CD4 mimetics sensitize HIV-1-infected cells to ADCC.The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cellsMother-to-Child HIV-1 Transmission Events Are Differentially Impacted by Breast Milk and Its Components from HIV-1-Infected Women.Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control.Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1Breast Milk of HIV-Positive Mothers Has Potent and Species-Specific In Vivo HIV-Inhibitory Activity.HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humansFCGR2A and FCGR3A Genotypes in Human Immunodeficiency Virus Mother-to-Child Transmission.Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular CytotoxicityDevelopment of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters.Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated CytotoxicityPostnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variantsNef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity
P2860
Q26753146-17327AC9-CA58-4067-9D6D-A53E580B0761Q26767258-A677D3D9-1544-4386-A3DD-62388DD88169Q27008774-1539C308-547C-4B23-991B-9F9F771D658FQ27320687-D88BBC58-0FC5-40FA-A62B-CE3198B28356Q27342615-E83FC4C5-3EAD-4363-B3FD-DE8B24A5602BQ27640572-025A7079-776F-4A31-8E3A-E0D07D5F7F37Q27675486-8ADB3733-1EE8-4BBA-9674-E57BE08E7E92Q30442849-D3230956-0D21-4879-8736-BFD08D8A272BQ33557844-FE7531F4-F263-4C30-9586-BD5B6CDC0820Q33603702-D61158B3-C67F-4CF6-B4FE-DB424DAED1C6Q33842522-DB49447D-3C98-4700-8828-416F631D36FCQ33924272-B02D37CD-91C4-4FF3-8FD7-4C7E8DFFF24EQ34057711-DB376F97-390A-473F-94E7-9519979E4D74Q34422051-5C614369-8E8F-47C1-9664-74F957EC74A5Q34540352-23910762-8129-4E39-8115-A12F9845B222Q34542687-B8B8DBD8-98E3-4D1C-84F3-4AA5052E02A2Q34598141-7F0ABC62-F61F-4022-8238-1E5BED8B372AQ34992575-06DAA6DE-E015-481A-A3C6-0157BE017D72Q34992670-69840839-6AF5-49F7-8E07-4931377D7E5CQ35000080-41452702-0A4A-4457-9968-A85E3319FB24Q35058698-15E3F706-077D-489E-BB27-7239EED03B94Q35195360-A15AF61E-59E8-4973-AE1C-E48302B2B79CQ35352866-25C8DAA0-C755-48DE-B2AE-C416DA28AF31Q35415717-F2F424B8-075F-409B-8B37-D60B58F490A0Q35619402-77837935-AFE8-4BC3-9AAA-19C224D017E3Q35644696-89F0B140-1C5D-4BA3-ADD5-412FF6E3508DQ35737800-D37BFFDA-B7E2-49C5-A7E2-8841EE614144Q35872338-36B47C62-10B4-488B-9571-7B1307794EAAQ35888710-4326D838-CEA5-4252-8222-08FF97316F48Q35913921-8BD7A8AA-AC53-4391-B04B-8DA9F52A5042Q36080800-9199728B-9FD4-4DE7-83EB-F948C2AAD7B2Q36208081-6A97ECB1-31A3-4FC9-9E77-438162026686Q36249933-92FE6675-5C52-4953-AD5D-27F0EE59CB7AQ36252656-32242510-AD63-4F76-9F5B-9B52181D288BQ36302010-BFF14176-2796-476A-86E4-872966304D01Q36434229-BDC60DDE-1566-4F51-A02C-B302D88D3852Q36479067-56955ABF-3EA1-49BA-8A0E-47CA85A9B7F0Q36538762-1088E18E-BDF1-4EA3-9D75-339125059781Q36588632-EDA46C36-3280-441D-9312-CA6D7B6C7EAAQ36736588-47EDA350-628C-4041-AA70-595A928076DF
P2860
HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
HIV-specific antibodies capabl ...... in women with high viral loads
@ast
HIV-specific antibodies capabl ...... in women with high viral loads
@en
HIV-specific antibodies capabl ...... in women with high viral loads
@en-gb
HIV-specific antibodies capabl ...... in women with high viral loads
@nl
type
label
HIV-specific antibodies capabl ...... in women with high viral loads
@ast
HIV-specific antibodies capabl ...... in women with high viral loads
@en
HIV-specific antibodies capabl ...... in women with high viral loads
@en-gb
HIV-specific antibodies capabl ...... in women with high viral loads
@nl
prefLabel
HIV-specific antibodies capabl ...... in women with high viral loads
@ast
HIV-specific antibodies capabl ...... in women with high viral loads
@en
HIV-specific antibodies capabl ...... in women with high viral loads
@en-gb
HIV-specific antibodies capabl ...... in women with high viral loads
@nl
P2093
P2860
P921
P3181
P1433
P1476
HIV-specific antibodies capabl ...... in women with high viral loads
@en
P2093
Dylan Peterson
Jennifer Mabuka
Katherine Odem-Davis
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1002739
P407
P577
2012-01-01T00:00:00Z